Net Cash Provided by (Used in) Operating Activities |
-3.3M |
USD |
-75.7% |
Q1 2025 |
Q1 2025 |
Net Cash Provided by (Used in) Financing Activities |
20.2M |
USD |
+1556% |
Q1 2025 |
Q1 2025 |
Net Cash Provided by (Used in) Investing Activities |
0 |
USD |
|
Q1 2025 |
Q1 2025 |
Common Stock, Shares Authorized |
100M |
shares |
+300% |
Q2 2025 |
Q2 2025 |
Common Stock, Shares, Issued |
25.5M |
shares |
+75.1% |
Q2 2025 |
Q2 2025 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2025 |
Q2 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
97.9M |
USD |
+262% |
Q2 2025 |
Q2 2025 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
0 |
USD |
|
Q1 2025 |
Q1 2025 |
Deferred Tax Assets, Valuation Allowance |
20.5M |
USD |
+3.54% |
Q4 2024 |
FY 2024 |
Deferred Tax Assets, Gross |
20.5M |
USD |
+3.54% |
Q4 2024 |
FY 2024 |
Deferred Tax Assets, Operating Loss Carryforwards |
17M |
USD |
+13.3% |
Q4 2024 |
FY 2024 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Q2 2025 |
Q2 2025 |
Preferred Stock, Shares Authorized |
10M |
shares |
0% |
Q2 2025 |
Q2 2025 |
Operating Lease, Payments |
8K |
USD |
0% |
Q1 2025 |
Q1 2025 |
Additional Paid in Capital |
270M |
USD |
+46.4% |
Q2 2025 |
Q2 2025 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q2 2025 |
Q2 2025 |
Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Q4 2024 |
FY 2024 |
Share-based Payment Arrangement, Expense |
3.1M |
USD |
+75% |
Q2 2025 |
Q2 2025 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2025 |
Q2 2025 |